| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 2 | 19 | 273 | 269 | - | - | - | 563 |
| - | - | - | - | - | 27 | 113 | - | - | - | 140 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| 1 |
| - |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| 64 |
| 178 |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME(L) | 563 | 89.5% | -2.01 | 140 | 44.0% |
| PLP(L) | 57 | 9.1% | 1.31 | 141 | 44.3% |
| CentralBrain-unspecified | 7 | 1.1% | 2.05 | 29 | 9.1% |
| SLP(L) | 0 | 0.0% | inf | 8 | 2.5% |
| AME(L) | 1 | 0.2% | -inf | 0 | 0.0% |
| Optic-unspecified(L) | 1 | 0.2% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns MeVP31 | % In | CV |
|---|---|---|---|---|---|
| MeTu3b (L) | 21 | ACh | 145 | 24.5% | 0.9 |
| Cm18 (L) | 11 | Glu | 65 | 11.0% | 0.7 |
| Dm-DRA1 (L) | 16 | Glu | 64 | 10.8% | 0.5 |
| R7d | 9 | HA | 30 | 5.1% | 0.9 |
| MeTu3a (L) | 12 | ACh | 22 | 3.7% | 0.6 |
| Mi15 (L) | 19 | ACh | 22 | 3.7% | 0.3 |
| SLP003 (L) | 1 | GABA | 20 | 3.4% | 0.0 |
| MeVC2 (R) | 1 | ACh | 19 | 3.2% | 0.0 |
| MeVPMe10 (R) | 2 | Glu | 19 | 3.2% | 0.2 |
| MeVP15 (L) | 9 | ACh | 16 | 2.7% | 1.1 |
| Tm34 (L) | 7 | Glu | 13 | 2.2% | 0.8 |
| aMe17e (L) | 1 | Glu | 10 | 1.7% | 0.0 |
| Cm8 (L) | 7 | GABA | 10 | 1.7% | 0.5 |
| Tm5c (L) | 7 | Glu | 9 | 1.5% | 0.4 |
| MeLo5 (L) | 5 | ACh | 7 | 1.2% | 0.6 |
| MeTu1 (L) | 5 | ACh | 7 | 1.2% | 0.6 |
| Cm22 (L) | 5 | GABA | 7 | 1.2% | 0.3 |
| Dm-DRA2 (L) | 3 | Glu | 6 | 1.0% | 0.4 |
| Cm14 (L) | 5 | GABA | 6 | 1.0% | 0.3 |
| SLP004 (L) | 1 | GABA | 5 | 0.8% | 0.0 |
| MeTu3c (L) | 3 | ACh | 5 | 0.8% | 0.6 |
| Cm21 (L) | 3 | GABA | 5 | 0.8% | 0.3 |
| MeVP22 (L) | 1 | GABA | 4 | 0.7% | 0.0 |
| LoVP1 (L) | 1 | Glu | 4 | 0.7% | 0.0 |
| mALD1 (R) | 1 | GABA | 4 | 0.7% | 0.0 |
| Tm35 (L) | 2 | Glu | 4 | 0.7% | 0.5 |
| Cm4 (L) | 3 | Glu | 4 | 0.7% | 0.4 |
| MeVP6 (L) | 3 | Glu | 4 | 0.7% | 0.4 |
| MeVC27 (R) | 3 | unc | 4 | 0.7% | 0.4 |
| MeVPMe9 (R) | 1 | Glu | 3 | 0.5% | 0.0 |
| Cm16 (L) | 2 | Glu | 3 | 0.5% | 0.3 |
| Dm2 (L) | 2 | ACh | 3 | 0.5% | 0.3 |
| MeTu2a (L) | 2 | ACh | 3 | 0.5% | 0.3 |
| Cm3 (L) | 3 | GABA | 3 | 0.5% | 0.0 |
| DNp27 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| Cm10 (L) | 1 | GABA | 2 | 0.3% | 0.0 |
| PLP186 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| Cm34 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| Tm37 (L) | 2 | Glu | 2 | 0.3% | 0.0 |
| MeVP14 (L) | 2 | ACh | 2 | 0.3% | 0.0 |
| aMe5 (L) | 2 | ACh | 2 | 0.3% | 0.0 |
| MeLo3b (L) | 2 | ACh | 2 | 0.3% | 0.0 |
| MeVC21 (L) | 2 | Glu | 2 | 0.3% | 0.0 |
| aMe4 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| Mi17 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| SLP267 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| MeTu4e (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| Mi10 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| TmY17 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| Cm23 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| Cm-DRA (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| MeVP11 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| PLP231 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| MeVP12 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| aMe10 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| MeVP21 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LoVP70 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| Lat5 (L) | 1 | unc | 1 | 0.2% | 0.0 |
| aMe12 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| aMe15 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHAD4a1 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| MeVP36 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CL063 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| downstream partner | # | NT | conns MeVP31 | % Out | CV |
|---|---|---|---|---|---|
| Cm22 (L) | 9 | GABA | 93 | 14.3% | 0.7 |
| Cm21 (L) | 7 | GABA | 40 | 6.1% | 0.6 |
| FB8B (L) | 2 | Glu | 36 | 5.5% | 0.3 |
| AOTU056 (L) | 4 | GABA | 28 | 4.3% | 0.6 |
| Cm18 (L) | 11 | Glu | 24 | 3.7% | 0.6 |
| MeVPaMe2 (L) | 1 | Glu | 23 | 3.5% | 0.0 |
| CL086_a (L) | 3 | ACh | 21 | 3.2% | 0.9 |
| CL234 (L) | 2 | Glu | 18 | 2.8% | 0.3 |
| MeVP38 (L) | 1 | ACh | 16 | 2.5% | 0.0 |
| Tm34 (L) | 3 | Glu | 16 | 2.5% | 1.1 |
| Cm8 (L) | 11 | GABA | 15 | 2.3% | 0.4 |
| SLP295 (L) | 2 | Glu | 14 | 2.2% | 0.1 |
| Tm5c (L) | 8 | Glu | 14 | 2.2% | 0.5 |
| PLP231 (L) | 2 | ACh | 12 | 1.8% | 0.3 |
| CB0937 (L) | 2 | Glu | 11 | 1.7% | 0.1 |
| CL086_d (L) | 1 | ACh | 10 | 1.5% | 0.0 |
| aMe24 (L) | 1 | Glu | 10 | 1.5% | 0.0 |
| aMe4 (L) | 5 | ACh | 10 | 1.5% | 0.4 |
| Pm12 (L) | 2 | GABA | 9 | 1.4% | 0.6 |
| aMe17b (L) | 2 | GABA | 9 | 1.4% | 0.6 |
| Cm12 (L) | 7 | GABA | 9 | 1.4% | 0.4 |
| DNpe035 (L) | 1 | ACh | 8 | 1.2% | 0.0 |
| MeVP6 (L) | 7 | Glu | 8 | 1.2% | 0.3 |
| PLP175 (L) | 1 | ACh | 7 | 1.1% | 0.0 |
| aMe23 (L) | 1 | Glu | 6 | 0.9% | 0.0 |
| PLP131 (L) | 1 | GABA | 6 | 0.9% | 0.0 |
| SMP528 (L) | 1 | Glu | 6 | 0.9% | 0.0 |
| Lat2 (L) | 2 | unc | 6 | 0.9% | 0.7 |
| CL365 (L) | 2 | unc | 6 | 0.9% | 0.7 |
| Cm10 (L) | 4 | GABA | 6 | 0.9% | 0.6 |
| s-LNv (L) | 2 | ACh | 6 | 0.9% | 0.0 |
| Cm14 (L) | 5 | GABA | 6 | 0.9% | 0.3 |
| aMe1 (L) | 1 | GABA | 5 | 0.8% | 0.0 |
| MeVP_unclear (L) | 1 | Glu | 5 | 0.8% | 0.0 |
| Cm5 (L) | 3 | GABA | 5 | 0.8% | 0.6 |
| MeLo5 (L) | 4 | ACh | 5 | 0.8% | 0.3 |
| CB2311 (L) | 1 | ACh | 4 | 0.6% | 0.0 |
| CL075_a (L) | 1 | ACh | 4 | 0.6% | 0.0 |
| MeVPaMe2 (R) | 1 | Glu | 4 | 0.6% | 0.0 |
| LoVCLo3 (R) | 1 | OA | 4 | 0.6% | 0.0 |
| aMe5 (L) | 2 | ACh | 4 | 0.6% | 0.5 |
| AOTU058 (L) | 2 | GABA | 4 | 0.6% | 0.5 |
| Cm16 (L) | 3 | Glu | 4 | 0.6% | 0.4 |
| MeVP12 (L) | 3 | ACh | 4 | 0.6% | 0.4 |
| Cm3 (L) | 4 | GABA | 4 | 0.6% | 0.0 |
| LoVP28 (L) | 1 | ACh | 3 | 0.5% | 0.0 |
| PLP080 (L) | 1 | Glu | 3 | 0.5% | 0.0 |
| MeTu3b (L) | 1 | ACh | 3 | 0.5% | 0.0 |
| DNp101 (L) | 1 | ACh | 3 | 0.5% | 0.0 |
| Tm35 (L) | 2 | Glu | 3 | 0.5% | 0.3 |
| DN1pA (L) | 2 | Glu | 3 | 0.5% | 0.3 |
| MeVP15 (L) | 3 | ACh | 3 | 0.5% | 0.0 |
| CL094 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| OLVC4 (L) | 1 | unc | 2 | 0.3% | 0.0 |
| LoVP60 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| Tm37 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| SLP315 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| CB3951b (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| aMe15 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| LoVC19 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| Cm35 (L) | 1 | GABA | 2 | 0.3% | 0.0 |
| CL087 (L) | 2 | ACh | 2 | 0.3% | 0.0 |
| CL086_b (L) | 2 | ACh | 2 | 0.3% | 0.0 |
| CL014 (L) | 2 | Glu | 2 | 0.3% | 0.0 |
| aMe12 (L) | 2 | ACh | 2 | 0.3% | 0.0 |
| MeTu3c (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| Cm6 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| SLP364 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| DNp27 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SLP438 (L) | 1 | unc | 1 | 0.2% | 0.0 |
| Cm20 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| Cm4 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| SMP331 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SLP267 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| SMP229 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| SLP322 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| MeVP3 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB1011 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| Mi17 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| CB3118 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| AOTU055 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| SMP357 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB4091 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| CB3001 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| MeTu1 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| T2a (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| MeTu2a (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| Pm4 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| PLP177 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| Mi1 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CL086_c (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| MeTu4a (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SLP459 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| PLP119 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| SLP064 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| Cm11c (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| PLP069 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| aMe10 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| PLP075 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LoVP42 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| OLVC4 (R) | 1 | unc | 1 | 0.2% | 0.0 |
| MeVC21 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| aMe9 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| PLP079 (L) | 1 | Glu | 1 | 0.2% | 0.0 |